首页> 外文期刊>Infection and immunity >Identification of an Essential Francisella tularensis subsp. tularensis Virulence Factor
【24h】

Identification of an Essential Francisella tularensis subsp. tularensis Virulence Factor

机译:基本弗朗西斯菌tularensis亚种的鉴定。 tularensis毒力因子

获取原文
           

摘要

Francisella tularensis, the highly virulent etiologic agent of tularemia, is a low-dose intracellular pathogen that is able to escape from the phagosome and replicate in the cytosol. Although there has been progress in identifying loci involved in the pathogenicity of this organism, analysis of the genome sequence has revealed few obvious virulence factors. We previously reported isolation of an F. tularensis subsp. tularensis strain Schu S4 transposon insertion mutant with a mutation in a predicted hypothetical lipoprotein, FTT1103, that was deficient in intracellular replication in HepG2 cells. In this study, a mutant with a defined nonpolar deletion in FTT1103 was created, and its phenotype, virulence, and vaccine potential were characterized. A phagosomal integrity assay and lysosome-associated membrane protein 1 colocalization revealed that ΔFTT1103 mutant bacteria were defective in phagosomal escape. FTT1103 mutant bacteria were maximally attenuated in the mouse model; mice survived, without visible signs of illness, challenge by more than 1010 CFU when the intranasal route was used and challenge by 106 CFU when the intraperitoneal, subcutaneous, or intravenous route was used. The FTT1103 mutant bacteria exhibited dissemination defects. Mice that were infected by the intranasal route had low levels of bacteria in their livers and spleens, and these bacteria were cleared by 3 days postinfection. Mutant bacteria inoculated by the subcutaneous route failed to disseminate to the lungs. BALB/c or C57BL/6 mice that were intranasally vaccinated with 108 CFU of FTT1103 mutant bacteria were protected against subsequent challenge with wild-type strain Schu S4. These experiments identified the FTT1103 protein as an essential virulence factor and also demonstrated the feasibility of creating defined attenuated vaccines based on a type A strain.
机译:图拉弗朗西菌tularensis 是图拉姆病的高毒病原体,是一种小剂量的细胞内病原体,能够从吞噬体中逃逸并在细胞质中复制。尽管在鉴定与这种生物的致病性有关的基因座方面已经取得了进展,但是对基因组序列的分析显示出几乎没有明显的毒力因子。我们之前曾报道过 F的隔离。 tularensis 子亚种 tularensis 菌株Schu S4转座子插入突变体,在预期的假设脂蛋白FTT1103中具有突变,该突变在HepG2细胞中的细胞内复制不足。在这项研究中,创建了一个在FTT1103中具有定义的非极性缺失的突变体,并对其表型,毒力和疫苗潜力进行了表征。吞噬体完整性检测和溶酶体相关的膜蛋白1共定位揭示ΔFTT1103突变细菌在吞噬体逃逸中存在缺陷。 FTT1103突变细菌在小鼠模型中最大程度地减毒。小鼠经鼻内途径攻击后存活超过10 10 CFU,而腹膜内,皮下或静脉内攻击则挑战10 6 CFU使用了路线。 FTT1103突变细菌表现出传播缺陷。经鼻内途径感染的小鼠的肝脏和脾脏细菌水平较低,感染后3天这些细菌被清除。皮下途径接种的突变细菌未能传播到肺部。鼻腔接种了FTT1103突变细菌的10 8 CFU的BALB / c或C57BL / 6小鼠可免受野生型Schu S4的攻击。这些实验将FTT1103蛋白鉴定为必需的毒力因子,并且还证明了基于A型毒株创建确定的减毒疫苗的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号